Abstract
The inhibition of RNA synthesis in vitro by the purine nucleoside analogue 6-chloro-8-aza-9-cyclopentylpurine has been characterized. This compound was found to be a noncompetitive inhibitor of the incorporation of nucleoside triphosphates into RNA by binding to DNA-dependent RNA polymerase (ribonucleoside triphosphate:RNA nucleotidyltransferase, EC 2.7.7.6) isolated from Escherichia coil. The DNA-binding and initiation functions of the enzyme were blocked, but the compound did not affect RNA chain elongation. Studies of the interactions of 6-chloro-8-aza-9-cyclopentylpurine with amino acids, N-acetylamino acid analogues, and β-mercaptoethanol indicated that the drug reacts primarily with sulfhydryl groups of RNA polymerase. The inhibition could be partially reversed by dithiothreitol. The data suggest that 6-chloro-8-aza-9-cyclopentylpurine acts by inhibiting RNA polymerase function in a manner similar to the reversible sulfhydryl inhibitor p-chloromercuribenzoate.
ACKNOWLEDGMENT The authors wish to thank Mrs. Donna Lundeen for her help in the preparation of the manuscript.
- Copyright ©, 1973, by Academic Press, Inc.
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|